Article info

Original research
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T

Authors

  1. Correspondence to Dr Charles Rosser; charles.rosser{at}cshs.org
View Full Text

Citation

Dorff T, Hirasawa Y, Acoba J, et al
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T

Publication history

  • Accepted July 11, 2021
  • First published August 10, 2021.
Online issue publication 
August 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.